Conditions: Parkinson's Disease
Keywords: Parkinson's Disease Cognition Rasagiline
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 170
Healthy volunteers: no

Brief summary:
This is a 24-week, multicenter, randomized, double-blind, placebo-controlled, add-on, parallel-group study to evaluate the effect of rasagiline on cognitive function in adults with mild cognitive impairment (MCI) in Parkinson's disease (PD-MCI).

Detailed description:

Arms:
arm 1: Rasagiline 1 mg oral tablets once daily for 24 weeks arm 2: Placebo oral tablets once daily for 24 weeks

Interventions: intervention 1: Rasagiline intervention 2: Placebo
Intervention descriptions: intervention 1: None intervention 2: None

Protocol document: